Skip to content
healthcare.dev
Get a free key

Reblozyl

NDC 59572-775, Luspatercept, injection, powder, lyophilized, for solution, from Celgene Corporation.

Product NDC
59572-775
Status
Listed
Labeler
Celgene Corporation
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761136
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59572-775 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LUSPATERCEPT75 mg/1

Pharmacologic classes

Erythroid Maturation Agent [EPC]; Increased Erythroid Cell Production [PE]

Package NDCNDC-11Package
59572-775-01595720775011 VIAL, GLASS in 1 CARTON (59572-775-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/82f4d266-3f52-41eb-86ba-0abf3cf468e8

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=59572-775

Use it

Look up 59572-775 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59572-775 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59572-775. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.